Intuitive Surgical (ISRG) Other Non-Current Liabilities (2009 - 2026)
Intuitive Surgical's (ISRG) quarterly Other Non-Current Liabilities came in at $656.0 million in Q2 2026, up 26.76% year-on-year from $517.5 million in Q2 2025, and up 8.83% quarter-over-quarter from $602.8 million in Q1 2026.
Intuitive Surgical (ISRG) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Intuitive Surgical's Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $656.0 million for Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 26.76% year-over-year to $656.0 million in Q2 2026; TTM through Jun 2026 was $656.0 million, a 26.76% increase from a year earlier, with the FY2025 full-year figure at $510.8 million, up 9.08% from the prior year.
- Other Non-Current Liabilities advanced to $656.0 million in Q2 2026 per ISRG's latest filing, from $602.8 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $656.0 million in Q2 2026 and bottomed at $365.9 million in Q2 2024.
- The 5-year median for Other Non-Current Liabilities is $449.7 million (2022), against an average of $461.3 million.
- Across the five-year window, Other Non-Current Liabilities dropped 12.25% in 2023 and soared 41.43% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $439.3 million in 2022, then decreased by 12.25% to $385.5 million in 2023, then gained by 21.48% to $468.3 million in 2024, then advanced by 9.08% to $510.8 million in 2025, then advanced by 28.43% to $656.0 million in 2026.
- Per Business Quant, the three latest ISRG Other Non-Current Liabilities figures stand at $656.0 million (Q2 2026), $602.8 million (Q1 2026), and $510.8 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 656.00 Mn |
| Mar 31, 2026 | 602.80 Mn |
| Dec 31, 2025 | 510.80 Mn |
| Sep 30, 2025 | 506.50 Mn |
| Jun 30, 2025 | 517.50 Mn |
| Mar 31, 2025 | 474.60 Mn |
| Dec 31, 2024 | 468.30 Mn |
| Sep 30, 2024 | 389.10 Mn |
| Jun 30, 2024 | 365.90 Mn |
| Mar 31, 2024 | 406.50 Mn |
| Dec 31, 2023 | 385.50 Mn |
| Sep 30, 2023 | 412.80 Mn |
| Jun 30, 2023 | 405.20 Mn |
| Mar 31, 2023 | 451.60 Mn |
| Dec 31, 2022 | 439.30 Mn |
| Sep 30, 2022 | 453.40 Mn |
| Jun 30, 2022 | 447.80 Mn |
| Mar 31, 2022 | 409.30 Mn |
| Dec 31, 2021 | 453.70 Mn |
| Sep 30, 2021 | 447.80 Mn |